![]() |
||||||||
|
|
| Table 2: | |
|
Industries
That Use Beryllium
|
|
|
Industries
With Heavy
Use of Beryllium |
Other
Industries That Use
Beryllium Less Heavily |
| Beryllium extraction | Aerospace |
| Beryllium and beryllium alloy machine shops | Ceramics |
| Electronics | Computers |
| Nuclear weapons manufacturing | Automotive |
| Dental appliances | |
| Table 3: |
|
Selected
Locations for Beryllium Lymphocyte
Proliferation Testing in the United States |
|
| Table 4: | ||
|
Clinical
and Laboratory Features of Chronic Beryllium Disease (CBD) and Sarcoidosis
|
||
|
Feature
|
Chronic
Beryllium Disease
|
Sarcoidosis
|
| Occupational exposure to beryllium |
Yes
|
No
|
| Onset |
Acute
or insidious
|
Acute
or insidious
|
| Respiratory symptoms |
Predominant
organ affected
|
Predominant
organ affected
|
| Erythyma nodosum |
No
|
Yes
|
| Dermatitis |
Yes
|
No
|
| Cardiac |
Rare
|
Common
|
|
Pulmonary |
Gas
exchange abnormalities common; obstruction early, mixed obstruction/restriction
or pure restriction late
|
Gas
exchange abnormalities common; restriction, obstruction, or mixed pattern
|
| Bilateral hilar adenopathy |
Uncommon
|
Common
|
| Infiltrates |
Diffuse
nodular or linear opacities, can be absent
|
Nodular
and/or linear opacities, may be more focal than in CBD
|
| Computed
tomography |
Small
nodules, septal lines, ground-glass appearance, adenopathy
|
Small
nodules, septal lines, adenopathy
|
| Beryllium
lymphocyte proliferation test |
Positive
|
Negative
|
| Granulomas |
Yes,
noncaseating granuloma
|
Yes,
noncaseating granuloma
|
| Other
histology |
Diffuse
mononuclear cell infiltrate common, bronchial submucosa
involved occasionally |
Diffuse
mononuclear cell infiltrate
common, bronchial submucosa involved occasionally |
| Beryllium in tissues |
Yes
|
No
|
| Skin tests | ||
| - Tuberculin |
Negative
|
Negative
|
| - Kveim |
Negative
|
Positive
|
| - Beryllium patch |
Positive
|
Negative
|
| Elevated serum angiotensin-converting enzyme |
Uncommon
|
Common
|
| Response
to steroid therapy |
Often
stabilizes disease, may improve pulmonary physiology and symptoms, usually
requires continuous therapy
|
Often
stabilizes disease that has not spontaneously remitted, may require continuous
therapy
|
| Prognosis |
Variable,
cor pulmonale and progressive fibrosis in some patients, more benign in
others
|
Good
prognosis for approximately 80%, may progress to end-stage fibrosis and
cor pulmonale.
|
|
This information is provided for general medical education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options of a specific patient's medical condition. In no event will The Cleveland Clinic Foundation be liable for any decision made or action taken in reliance upon the information provided through this web site. |
|
Copyright
2004 The Cleveland Clinic Foundation
|